現在の一部のトップ Biotechnology 株：Vertex Pharmaceuticals Inc (VRTX +3.44%), Moderna, Inc. Common Stock (MRNA +13.11%), Regeneron Pharmaceuticals Inc (REGN -4.39%), argenx SE American Depositary Shares (ARGX +3.36%)。
以下の表は合計 596 の Biotechnology 株を示しており、それぞれが Biotechnology 業界の様相に貢献しています。株価、取引数量、または時価総額に基づいて株をランク付けして、特定の投資の好みに合わせて表を簡単にカスタマイズできます。
シンボル | 名前 | 価格 | 時価総額 | 取引高 | % (1D) | % (1M) | % (6M) | |
|---|---|---|---|---|---|---|---|---|
 Vertex Pharmaceuticals Inc | $549.04 | 139.16B | 1.81M | +3.44% | +8.78% | +27.73% | ||
MRNAE |  Moderna, Inc. Common Stock | $258.38 | 103.15B | 14.71M | +13.11% | +35.98% | +446.26% | |
 Regeneron Pharmaceuticals Inc | $930.67 | 96.28B | 1.38M | -4.39% | +26.59% | +31.23% | ||
 argenx SE American Depositary Shares | $931.38 | 58.57B | 646.42K | +3.36% | +1.32% | +14.83% | ||
 Revolution Medicines, Inc. Common Stock | $199.70 | 42.80B | 2.47M | +2.82% | -3.36% | +35.02% | ||
ONCE |  BeOne Medicines Ltd. American Depositary Shares | $377.78 | 42.74B | 630.65K | +6.42% | +5.50% | +27.14% | |
GMABE |  Genmab A/S ADS | $55.12 | 33.89B | 4.23M | -0.72% | +58.62% | +103.85% | |
 Royalty Pharma plc Class A Ordinary Shares | $67.56 | 30.08B | 3.80M | +1.75% | +18.19% | +34.58% | ||
ROIVE |  Roivant Sciences Ltd. Common Shares | $38.23 | 27.61B | 10.92M | +6.08% | +7.03% | +34.80% | |
 Incyte Genomics Inc | $122.85 | 25.04B | 2.06M | +4.47% | +6.55% | +26.47% | ||
 Insmed, Inc. | $110.00 | 24.13B | 4.94M | +5.32% | -1.01% | -21.43% | ||
 BioNTech SE American Depositary Share | $90.70 | 22.78B | 1.35M | +4.35% | -6.40% | -8.71% | ||
 Alnylam Pharmaceuticals, Inc. | $161.08 | 21.57B | 3.47M | +0.74% | -26.69% | -45.93% | ||
 Exelixis Inc | $72.75 | 17.75B | 2.85M | +0.61% | +24.59% | +64.70% | ||
ASNDE |  Ascendis Pharma A/S Ordinary Share | $257.93 | 16.97B | 655.90K | +3.10% | +13.19% | +12.78% | |
 Jazz Pharmaceuticals, Inc. | $234.66 | 15.23B | 898.45K | +2.14% | -0.43% | +12.78% | ||
 BridgeBio Pharma, Inc. Common Stock | $77.89 | 15.17B | 5.56M | +5.21% | +15.82% | +12.90% | ||
HALOE |  Halozyme Therapeutics, Inc. | $130.34 | 14.79B | 1.59M | +1.34% | +18.64% | +101.86% | |
SMMTE |  Summit Therapeutics Inc. Common Stock | $16.17 | 12.90B | 4.25M | +2.34% | -3.49% | -4.77% | |
 Kymera Therapeutics, Inc. Common Stock | $136.25 | 11.63B | 1.61M | +7.21% | +26.87% | +63.00% | ||
 Bio-Techne Corp. | $72.73 | 11.42B | 4.21M | +0.10% | +0.46% | +32.86% | ||
 BioMarin Pharmaceuticals Inc | $57.13 | 11.06B | 2.84M | +2.64% | -0.09% | +3.01% | ||
 Vaxcyte, Inc. Common Stock | $65.68 | 10.34B | 2.24M | +8.01% | +16.29% | +12.29% | ||
 ImmunityBio, Inc. Common Stock | $8.93 | 9.46B | 9.69M | +7.72% | -13.17% | +20.19% | ||
TWSTE |  Twist Bioscience Corporation Common Stock | $142.58 | 9.45B | 1.88M | +1.63% | -24.43% | +153.75% | |
TGTXE |  TG Therapeutics, Inc. | $61.63 | 9.43B | 1.89M | +1.45% | +13.52% | +72.61% | |
 Caris Life Sciences, Inc. Common Stock | $33.22 | 9.39B | 4.07M | +1.13% | +17.39% | +77.74% | ||
PTGXE |  Protagonist Therapeutics, Inc | $143.37 | 9.28B | 713.90K | +2.23% | +2.36% | +44.06% | |
 Spyre Therapeutics, Inc. Common Stock | $99.04 | 9.26B | 1.47M | -0.23% | +6.28% | +43.27% | ||
 Madrigal Pharmaceuticals, Inc. Common Stock | $400.43 | 9.25B | 2.31M | +1.04% | -19.82% | -22.80% | ||
 Krystal Biotech, Inc. Common Stock | $310.84 | 9.20B | 386.60K | +1.90% | -3.55% | +8.33% | ||
 Cytokinetics Inc. | $63.60 | 8.84B | 2.69M | +2.07% | -3.05% | -3.71% | ||
 ARROWHEAD PHARMACEUTICALS, INC. | $61.65 | 8.71B | 1.49M | +3.56% | -3.96% | -19.30% | ||
 Corcept Therapeutics Inc. | $79.22 | 8.56B | 2.12M | -3.31% | -31.84% | +53.53% | ||
PRAXE |  Praxis Precision Medicines, Inc. Common Stock | $284.79 | 7.95B | 304.69K | +1.53% | -3.63% | -15.65% | |
 Abivax SA American Depositary Shares | $89.49 | 7.83B | 568.18K | +0.88% | -3.65% | -23.60% | ||
 Rhythm Pharmaceuticals, Inc. Common Stock | $110.68 | 7.62B | 5.36M | +28.04% | +19.23% | +29.33% | ||
 Axsome Therapeutics, Inc | $137.00 | 7.18B | 1.03M | -1.87% | -23.57% | -38.76% | ||
ORKAE |  Oruka Therapeutics, Inc. Common Stock | $101.41 | 6.71B | 790.70K | +1.87% | +19.98% | +52.59% | |
IONSE |  Ionis Pharmaceuticals, Inc. Common Stock | $40.15 | 6.67B | 3.89M | -0.67% | -7.79% | -46.79% | |
 Ligand Pharmaceuticals Inc. | $316.13 | 6.32B | 179.95K | +0.83% | +4.35% | +38.43% | ||
 Mirum Pharmaceuticals, Inc. Common Stock | $96.97 | 6.30B | 1.15M | +11.42% | +16.93% | -8.34% | ||
BLTEE |  Belite Bio, Inc American Depositary Shares | $154.01 | 6.20B | 82,864 | +1.21% | -3.48% | -0.32% | |
KODE |  Kodiak Sciences Inc Common Stock | $98.51 | 6.19B | 1.00M | -0.38% | +4.30% | +133.10% | |
IMVTE |  Immunovant, Inc. Common Stock | $29.90 | 6.18B | 1.11M | +2.96% | -11.06% | +7.36% | |
CGONE |  CG Oncology, Inc. Common stock | $67.71 | 6.00B | 1.31M | +5.70% | +0.49% | +0.01% | |
 PTC Therapeutics, Inc. | $68.97 | 5.76B | 1.27M | +1.25% | +8.68% | +5.31% | ||
MANEE |  Veradermics, Incorporated | $136.51 | 5.70B | 561.95K | +2.17% | +16.92% | +29.69% | |
SRRKE |  Scholar Rock Holding Corporation Common Stock | $46.09 | 5.61B | 1.71M | +4.80% | -1.54% | -0.84% | |
COGTE |  Cogent Biosciences, Inc. Common Stock | $31.49 | 5.46B | 2.23M | +1.38% | +1.52% | -14.27% | |
ERASE |  Erasca, Inc. Common Stock | $14.91 | 5.21B | 3.50M | +1.84% | +1.15% | +47.04% | |
 CRISPR Therapeutics AG | $51.78 | 5.01B | 1.39M | +3.57% | -6.59% | -3.37% | ||
 Travere Therapeutics, Inc. Common Stock | $52.42 | 4.94B | 3.57M | +6.09% | -7.92% | +16.72% | ||
 Dianthus Therapeutics, Inc. Common Stock | $85.81 | 4.80B | 1.68M | +3.76% | -2.72% | -3.95% | ||
LEGNE |  Legend Biotech Corporation American Depositary Shares | $22.77 | 4.43B | 3.16M | +6.01% | +22.62% | -14.08% | |
DFTXE |  Definium Therapeutics, Inc. Common Shares | $32.70 | 4.39B | 1.41M | -2.13% | -12.57% | +50.34% | |
 Arcutis Biotherapeutics, Inc. Common Stock | $34.05 | 4.28B | 2.58M | +6.41% | +35.33% | +44.96% | ||
EWTXE |  Edgewise Therapeutics, Inc. Common Stock | $37.53 | 4.08B | 1.03M | -0.40% | -9.35% | +19.33% | |
ABCLE |  AbCellera Biologics Inc. Common Shares | $12.28 | 3.98B | 2.67M | +0.82% | -10.63% | +167.54% | |
 Relay Therapeutics, Inc. Common Stock | $18.03 | 3.95B | 3.68M | +3.38% | -4.91% | +37.74% | ||
IOVAE |  Iovance Biotherapeutics, Inc. Common Stock | $8.70 | 3.94B | 17.26M | -1.47% | -38.80% | +125.97% | |
 Tango Therapeutics, Inc. | $23.18 | 3.91B | 2.47M | +0.04% | -0.26% | +2.07% | ||
XENEE |  Xenon Pharmaceuticals Inc | $39.19 | 3.80B | 1.63M | +2.51% | +3.08% | -31.72% | |
PBLSE |  Parabilis Medicines, Inc. Common Stock | $30.36 | 3.75B | 843.32K | +3.79% | +0.26% | 0.00% | |
 Acadia Pharmaceuticals Inc. | $21.47 | 3.70B | 4.55M | +4.38% | +7.62% | -3.24% | ||
IRONE |  Disc Medicine, Inc. Common Stock | $83.28 | 3.70B | 1.43M | +2.61% | +29.10% | +23.12% | |
 Viking Therapeutics, Inc | $27.97 | 3.57B | 4.03M | +7.21% | -6.58% | -11.93% | ||
 Dyne Therapeutics, Inc. Common Stock | $18.54 | 3.46B | 3.65M | +2.71% | +21.97% | +4.69% | ||
ELVNE |  Enliven Therapeutics, Inc. Common Stock | $47.25 | 3.46B | 2.71M | +5.40% | +0.60% | +13.55% | |
CELCE |  Celcuity Inc. Common Stock | $69.24 | 3.39B | 1.20M | -0.69% | -3.97% | -52.24% | |
 Denali Therapeutics Inc. Common Stock | $20.96 | 3.35B | 4.65M | +7.76% | +4.80% | +12.27% | ||
 Viridian Therapeutics, Inc. Common Stock | $29.06 | 3.29B | 11.17M | +15.53% | +49.77% | +106.65% | ||
 Telix Pharmaceuticals Limited American Depositary Shares | $9.67 | 3.29B | 531.81K | +7.09% | -8.34% | -13.27% | ||
 Tarsus Pharmaceuticals, Inc. Common Stock | $69.07 | 3.23B | 2.55M | -4.91% | -5.38% | +6.97% | ||
 IDEAYA Biosciences, Inc. Common Stock | $32.36 | 3.12B | 1.90M | +3.29% | -13.38% | +11.97% | ||
 Beam Therapeutics Inc. Common Stock | $27.79 | 2.87B | 1.35M | +5.55% | +13.43% | -7.61% | ||
ZLABE |  Zai Lab Limited American Depositary Shares | $22.80 | 2.83B | 806.40K | +3.83% | -6.29% | +7.45% | |
 Xencor, Inc. | $35.03 | 2.60B | 2.41M | +14.33% | +41.02% | +162.20% | ||
MBXE |  MBX Biosciences, Inc. Common Stock | $52.48 | 2.53B | 425.48K | -4.58% | -10.31% | +78.26% | |
 NewAmsterdam Pharma Company N.V. Ordinary Shares | $20.93 | 2.50B | 1.89M | +5.18% | -9.78% | -29.91% | ||
 Arcus Biosciences, Inc. | $19.31 | 2.46B | 2.08M | +2.12% | -20.99% | -25.87% | ||
PHVSE |  Pharvaris N.V. Ordinary Shares | $34.33 | 2.41B | 309.43K | -1.29% | +10.07% | +14.36% | |
CLDXE |  Celldex Therapeutics, Inc | $29.93 | 2.35B | 749.93K | +0.74% | -5.43% | -8.67% | |
 ADMA Biologics, Inc. | $10.48 | 2.35B | 13.29M | -5.67% | +7.82% | +1.65% | ||
PVLAE |  Palvella Therapeutics, Inc. Common Stock | $162.28 | 2.34B | 404.41K | +6.11% | +22.50% | +27.17% | |
VCELE |  Vericel Corporation | $45.48 | 2.33B | 1.74M | +10.68% | +13.28% | +24.64% | |
 Recursion Pharmaceuticals, Inc. Class A Common Stock | $3.88 | 2.32B | 20.56M | +5.43% | -5.83% | +10.23% | ||
VERAE |  Vera Therapeutics, Inc. Class A Common Stock | $31.97 | 2.30B | 1.88M | +4.10% | +5.10% | -9.97% | |
IMNME |  Immunome, Inc. | $19.52 | 2.30B | 3.31M | -3.89% | -6.60% | -16.33% | |
 Biohaven Ltd. | $15.24 | 2.30B | 1.67M | -2.37% | +18.41% | +50.30% | ||
 Aurinia Pharmaceuticals Inc | $17.11 | 2.29B | 1.48M | +3.32% | +8.09% | +8.50% | ||
 Lakefront Biotherapeutics American Depositary Shares | $34.09 | 2.25B | 447.40K | +6.03% | +16.07% | 0.00% | ||
SEPNE |  Septerna, Inc. Common Stock | $47.88 | 2.23B | 605.02K | +9.57% | +26.97% | +92.91% | |
ZYMEE |  Zymeworks Inc. | $30.94 | 2.22B | 1.05M | +2.69% | +23.02% | +15.53% | |
COAGE |  Hemab Therapeutics Holdings, Inc. Common Stock | $45.09 | 2.11B | 499.86K | +4.62% | +44.94% | +77.94% | |
 First Tracks Biotherapeutics, Inc. Ordinary Shares | $49.04 | 2.06B | 880.03K | +5.83% | +47.36% | +138.64% | ||
 Fortrea Holdings Inc. Common Stock | $20.83 | 2.01B | 1.43M | -0.57% | +4.15% | +70.04% | ||
SRPTE |  Sarepta Therapeutics,, Inc. Common Stock | $18.99 | 2.01B | 1.33M | +2.43% | +8.51% | -13.84% | |
 Harmony Biosciences Holdings, Inc. Common Stock | $34.42 | 2.00B | 2.45M | -7.04% | -13.18% | +5.60% | ||
TRVIE |  Trevi Therapeutics, Inc. Common Stock | $13.99 | 1.99B | 1.38M | +0.90% | +0.54% | -2.75% | |
 Vir Biotechnology, Inc. Common Stock | $11.77 | 1.99B | 2.42M | +4.90% | +5.37% | +15.62% | ||
 Replimune Group, Inc. | $20.69 | 1.96B | 3.08M | +0.19% | +58.30% | +582.84% | ||
AGIOE |  Agios Pharmaceuticals, Inc. | $31.38 | 1.87B | 916.78K | +0.58% | -1.32% | +13.86% | |
 Mesoblast Limited American Depositary Shares | $14.29 | 1.86B | 351.77K | -3.25% | +1.49% | -10.69% | ||
 Zenas BioPharma, Inc. Common Stock | $28.46 | 1.85B | 802.14K | +0.28% | +0.58% | +32.00% | ||
MAZEE |  Maze Therapeutics, Inc. Common Stock | $33.38 | 1.85B | 536.61K | +3.50% | +26.30% | +23.95% | |
SLSE |  SELLAS Life Sciences Group, Inc. Common Stock | $9.14 | 1.85B | 5.41M | +3.04% | -22.15% | +82.07% | |
GENBE |  Generate Biomedicines, Inc. Common Stock | $14.16 | 1.82B | 635.51K | +2.24% | +3.43% | -2.07% | |
 Braveheart Bio, Inc. Common Stock | $20.11 | 1.81B | 656.00K | -6.01% | -5.48% | 0.00% | ||
 Precigen, Inc. Common Stock | $5.06 | 1.81B | 10.26M | -3.71% | -40.81% | +22.10% | ||
ABSIE |  Absci Corporation Common Stock | $10.48 | 1.80B | 4.16M | +4.80% | -5.33% | +86.48% | |
 Stoke Therapeutics, Inc. Common Stock | $27.45 | 1.77B | 1.15M | +1.70% | +7.14% | -19.69% | ||
NVAXE |  Novavax Inc | $10.65 | 1.76B | 5.96M | +10.02% | +1.82% | +32.63% | |
 Nurix Therapeutics, Inc. Common stock | $15.95 | 1.74B | 19.57M | -38.23% | -30.62% | -5.79% | ||
NTLAE |  Intellia Therapeutics, Inc | $12.31 | 1.72B | 2.95M | +3.79% | +0.41% | -11.25% | |
 Ultragenyx Pharmaceutical Inc. | $17.16 | 1.69B | 7.34M | +3.19% | +12.75% | -30.83% | ||
 Nuvation Bio Inc. | $4.73 | 1.66B | 8.35M | +0.85% | -7.98% | +7.26% | ||
KLRAE |  Kailera Therapeutics, Inc. Common Stock | $12.80 | 1.66B | 651.03K | +1.75% | +23.20% | -48.98% | |
 ADARx Pharmaceuticals, Inc. Common Stock | $14.96 | 1.60B | 378.01K | -7.02% | -18.03% | -41.45% | ||
 uniQure N.V. | $23.03 | 1.60B | 2.55M | -3.52% | -1.83% | +11.36% | ||
OCULE |  Ocular Therapeutix, Inc. | $7.14 | 1.57B | 3.36M | +4.69% | +2.59% | -26.92% | |
 Innoviva, Inc. Common Stock | $21.26 | 1.54B | 917.08K | +1.58% | +3.71% | -7.53% | ||
 Nanobiotix S.A. American Depositary Shares | $29.70 | 1.51B | 230.34K | +3.99% | +15.34% | -4.69% | ||
 Lycia Therapeutics, Inc. Common Stock | $28.92 | 1.51B | 302.72K | +4.78% | 0.00% | 0.00% | ||
IMCRE |  Immunocore Holdings plc American Depositary Shares | $29.23 | 1.51B | 684.22K | -2.66% | -1.62% | +2.49% | |
 Mineralys Therapeutics, Inc. Common Stock | $17.00 | 1.50B | 1.93M | +6.32% | -28.06% | -42.66% | ||
 Tyra Biosciences, Inc. Common Stock | $21.53 | 1.48B | 542.86K | +0.73% | +5.36% | -38.75% | ||
RAPPE |  Rapport Therapeutics, Inc. Common Stock | $25.93 | 1.46B | 956.87K | +1.93% | -19.40% | -27.02% | |
KARDE |  Kardigan, Inc. Common Stock | $15.56 | 1.45B | 490.81K | +8.66% | +5.21% | 0.00% | |
GPCRE |  Structure Therapeutics Inc. American Depositary Shares | $20.36 | 1.45B | 736.53K | +0.05% | -26.42% | -52.70% | |
 Taysha Gene Therapies, Inc. Common Stock | $4.36 | 1.42B | 3.68M | +6.60% | -5.83% | -34.34% | ||
 AnaptysBio, Inc. Common Stock | $47.51 | 1.42B | 493.53K | -0.46% | -2.10% | -31.91% | ||
DMRAE |  Damora Therapeutics, Inc. Ordinary Shares | $22.94 | 1.42B | 736.97K | +3.89% | +11.09% | -11.53% | |
 Ascentage Pharma Group International American Depository Shares | $15.07 | 1.41B | 19,658 | +11.80% | -1.92% | -31.56% | ||
 UroGen Pharma Ltd. Ordinary Shares | $28.74 | 1.40B | 2.89M | -16.45% | -30.58% | +23.40% | ||
KRSAE |  Korsana Biosciences, Inc. Common Stock | $30.56 | 1.39B | 122.72K | -4.38% | +0.23% | 0.00% | |
GHRSE |  GH Research PLC Ordinary Shares | $19.93 | 1.37B | 297.75K | -1.73% | -13.12% | -8.11% | |
LBRXE |  LB Pharmaceuticals Inc Common Stock | $40.85 | 1.32B | 365.77K | +1.29% | +10.44% | +28.34% | |
OMERE |  Omeros Corporation | $18.18 | 1.32B | 976.43K | -0.49% | -2.31% | +21.93% | |
NKTRE |  Nektar Therapeutics | $38.48 | 1.31B | 492.05K | +1.91% | -11.70% | -55.71% | |
 Alpha Tau Medical Ltd. Ordinary Shares | $14.03 | 1.30B | 685.89K | +3.62% | -5.01% | +86.32% | ||
INBXE |  Inhibrx Biosciences, Inc. Common Stock | $86.76 | 1.28B | 190.20K | +7.01% | -10.55% | -32.19% | |
MNKDE |  Mannkind Corporation | $3.93 | 1.26B | 3.82M | +5.36% | +3.42% | +39.86% | |
 Vor Biopharma Inc. Common Stock | $20.12 | 1.24B | 414.07K | +1.31% | +7.65% | +36.78% | ||
SLNE |  Silence Therapeutics Plc American Depository Share | $19.80 | 1.23B | 1.02M | +0.10% | +86.09% | +171.60% | |
AVLNE |  Avalyn Pharma Inc. Common Stock | $27.47 | 1.22B | 457.02K | +2.46% | -2.35% | -5.50% | |
VSTME |  Verastem, Inc. | $9.85 | 1.20B | 2.51M | +0.82% | +27.92% | +65.55% | |
SGPE |  SpyGlass Pharma, Inc. Common Stock | $34.45 | 1.15B | 201.11K | 0.00% | +38.24% | +41.13% | |
 Maravai LifeSciences Holdings, Inc. Class A Common Stock | $7.72 | 1.15B | 3.62M | +3.62% | -2.28% | +103.69% | ||
 Seaport Therapeutics, Inc. Common Stock | $20.96 | 1.12B | 336.53K | +3.76% | +13.79% | +23.29% | ||
JANXE |  Janux Therapeutics, Inc. Common Stock | $18.18 | 1.11B | 974.48K | +2.02% | +7.38% | +26.07% | |
IMTXE |  Immatics N.V. Ordinary Shares | $6.91 | 1.05B | 678.89K | -2.33% | -8.96% | -37.97% | |
 MoonLake Immunotherapeutics Class A Ordinary Shares | $11.56 | 983.83M | 1.21M | -1.20% | +1.31% | -34.17% | ||
ORICE |  Oric Pharmaceuticals, Inc. Common Stock | $9.34 | 968.12M | 2.96M | -2.61% | -23.47% | -3.01% | |
RIGLE |  Rigel Pharmaceuticals Inc. (New) | $51.29 | 958.09M | 270.30K | +4.97% | +8.78% | +73.63% | |
SVRAE |  Savara Inc. | $4.66 | 957.44M | 3.56M | -1.89% | -3.12% | -12.08% | |
JBIOE |  Jade Biosciences, Inc. Common Stock | $15.04 | 956.50M | 1.14M | +3.23% | +6.52% | -38.66% | |
 Odyssey Therapeutics, Inc. Common Stock | $19.50 | 937.14M | 675.90K | -9.60% | -5.91% | 0.00% | ||
 Syndax Pharmaceuticals, Inc. | $10.45 | 933.15M | 14.90M | -26.87% | -40.63% | -47.65% | ||
 Latigo Biotherapeutics, Inc. Common Stock | $14.04 | 930.84M | 156.05K | -3.64% | -11.70% | 0.00% | ||
GLUEE |  Monte Rosa Therapeutics, Inc. Common Stock | $10.82 | 923.09M | 1.96M | +3.94% | +3.05% | -44.71% | |
ANROE |  Alto Neuroscience Inc. | $23.30 | 914.34M | 449.16K | +2.64% | -6.05% | -7.50% | |
 Inventiva S.A. American Depository Shares | $3.87 | 914.23M | 1.58M | -3.97% | +8.71% | -26.57% | ||
MGTXE |  MeiraGTx Holdings plc Ordinary Shares | $9.42 | 904.73M | 597.87K | -1.05% | -12.70% | -2.89% | |
PRMEE |  Prime Medicine, Inc. Common Stock | $4.97 | 901.44M | 4.40M | +9.23% | +66.78% | +43.23% | |
CRVSE |  Corvus Pharmaceuticals, Inc. | $10.57 | 889.16M | 1.27M | +7.53% | -3.03% | -34.02% | |
 Pharming Group N.V. ADS, each representing 10 ordinary shares | $12.46 | 881.90M | 26,883 | -3.63% | +27.79% | -23.98% | ||
 Ardelyx, Inc. | $3.29 | 849.44M | 10.58M | +8.58% | -1.50% | -54.93% | ||
ALMSE |  Alumis Inc. Common Stock | $6.55 | 847.80M | 1.29M | +0.77% | -4.38% | -74.06% | |
AKTSE |  Aktis Oncology, Inc. Common stock | $15.20 | 845.42M | 243.41K | +1.74% | -17.93% | -20.00% | |
 City Therapeutics, Inc. Common Stock | $16.41 | 825.95M | 360.57K | -14.04% | 0.00% | 0.00% | ||
ANNXE |  Annexon, Inc. Common Stock | $4.33 | 820.88M | 4.44M | +3.34% | +3.34% | -23.90% | |
ABUSE |  Arbutus Biopharma Corporation Common Stock | $4.06 | 804.31M | 2.39M | +4.64% | -8.76% | -7.52% | |
CGEME |  Cullinan Therapeutics, Inc. Common Stock | $12.49 | 803.79M | 2.20M | -20.70% | -19.47% | -18.58% | |
 Bambusa Therapeutics, Inc. Common Stock | $16.07 | 799.67M | 252.36K | +0.44% | 0.00% | 0.00% | ||
DNAE |  Ginkgo Bioworks Holdings, Inc. | $11.65 | 784.51M | 2.69M | +8.27% | -5.67% | +17.56% | |
SANAE |  Sana Biotechnology, Inc. Common Stock | $2.56 | 766.36M | 2.63M | +4.92% | -11.42% | -24.93% | |
 OmniAb, Inc. Common Stock | $5.18 | 755.56M | 1.14M | +0.58% | +6.37% | +267.38% | ||
ACHVE |  Achieve Life Sciences, Inc. | $6.98 | 719.66M | 1.40M | +3.71% | -3.59% | +59.00% | |
 Wave Life Sciences Ltd. Ordinary Shares | $3.62 | 713.97M | 2.74M | +1.12% | -4.23% | -51.54% | ||
 Attovia Therapeutics, Inc. Common Stock | $15.60 | 712.16M | 328.09K | +2.16% | -9.14% | +3,209% | ||
SGMTE |  Sagimet Biosciences Inc. Series A Common Stock | $9.99 | 708.38M | 756.26K | +0.40% | +9.30% | +26.46% | |
 Solid Biosciences Inc. Common Stock | $6.52 | 699.11M | 1.06M | +3.82% | -4.82% | -9.82% | ||
 Geron Corp | $1.08 | 693.87M | 26.82M | +16.13% | -10.00% | -31.21% | ||
CADLE |  Candel Therapeutics, Inc. Common Stock | $9.05 | 692.49M | 994.54K | +2.61% | -11.10% | +20.19% | |
AURAE |  Aura Biosciences, Inc. Common Stock | $6.65 | 689.64M | 1.00M | +6.57% | +9.20% | -20.36% | |
 Obsidian Therapeutics, Inc. Common Stock | $10.99 | 678.88M | 545.36K | -16.93% | -19.13% | 0.00% | ||
FDMTE |  4D Molecular Therapeutics, Inc. Common Stock | $12.28 | 678.40M | 765.24K | +2.76% | -10.17% | +30.08% | |
KURAE |  Kura Oncology, Inc. | $7.61 | 676.99M | 7.93M | -22.98% | -28.54% | -17.73% | |
 Design Therapeutics, Inc. Common Stock | $10.63 | 665.24M | 315.62K | +2.80% | -13.86% | -19.29% | ||
AVBPE |  ArriVent BioPharma, Inc. Common Stock | $13.49 | 665.16M | 1.63M | +3.61% | -52.28% | -55.60% | |
 Zevra Therapeutics, Inc. Common Stock | $11.17 | 663.32M | 2.07M | +8.87% | +11.81% | +11.14% | ||
IMMXE |  Immix Biopharma, Inc. Common Stock | $7.97 | 660.74M | 1.24M | +3.37% | -17.67% | -15.93% | |
OLMAE |  Olema Pharmaceuticals, Inc. Common Stock | $7.54 | 659.73M | 1.09M | +2.59% | -8.33% | -48.46% | |
LXRXE |  Lexicon Pharmaceuticals, Inc. | $1.48 | 658.53M | 1.95M | +1.37% | -18.68% | -7.50% | |
 Apnimed, Inc. Common Stock | $15.30 | 636.95M | 603.99K | +1.59% | -28.87% | 0.00% | ||
 Iambic Therapeutics, Inc. Common Stock | $13.40 | 635.17M | 293.04K | -0.67% | 0.00% | 0.00% | ||
HELPE |  Helus Pharma Inc. | $8.68 | 634.24M | 1.23M | -3.88% | -25.81% | +64.08% | |
 DBV Technologies S.A. American Depositary Shares | $9.94 | 624.64M | 378.36K | -1.68% | -5.78% | -48.95% | ||
 SL Science Holding Limited Ordinary Shares | $1.11 | 622.44M | 39,584 | -9.02% | -29.30% | 0.00% |